Swaytha V Yalamanchi1, Kerry J Stewart2, Nan Ji3, Sherita H Golden4, Adrian Dobs1, Diane M Becker5, Dhananjay Vaidya5, Brian G Kral6, Rita R Kalyani7. 1. Division of Endocrinology, Diabetes & Metabolism, Department of Medicine, The Johns Hopkins University, Baltimore, MD, United States. 2. Division of Cardiology, Department of Medicine, The Johns Hopkins University, Baltimore, MD, United States. 3. Welch Center for Prevention, Epidemiology, and Clinical Research, The Johns Hopkins University, Baltimore, MD, United States. 4. Division of Endocrinology, Diabetes & Metabolism, Department of Medicine, The Johns Hopkins University, Baltimore, MD, United States; Welch Center for Prevention, Epidemiology, and Clinical Research, The Johns Hopkins University, Baltimore, MD, United States. 5. Division of General Internal Medicine, The Johns Hopkins University, Baltimore, MD, United States. 6. Division of Cardiology, Department of Medicine, The Johns Hopkins University, Baltimore, MD, United States; Division of General Internal Medicine, The Johns Hopkins University, Baltimore, MD, United States. 7. Division of Endocrinology, Diabetes & Metabolism, Department of Medicine, The Johns Hopkins University, Baltimore, MD, United States; Center on Aging and Health, Johns Hopkins Medical Institutions, Baltimore, MD, United States. Electronic address: rrastogi@jhmi.edu.
Abstract
AIMS: Exercise training (ET) has been variably associated with body composition changes among persons with type 2 diabetes (T2DM). The degree to which these changes are related to hyperglycemia remains unclear. Our objective was to investigate the relationship of baseline fasting glucose (FG) to the magnitude of muscle gains and fat loss after ET in individuals with T2DM. METHODS: Participants were enrolled in the SHAPE-2 trial, a six month supervised aerobic and resistance training intervention (three days/week), at Johns Hopkins. This was a post hoc single arm intervention study of participants who completed theexercise intervention (n=50). Participants were aged 40-65years and had T2DM that was not treated with insulin. Body composition was assessed by DEXA. RESULTS: After 6months of ET, total fat mass decreased (-2.1±3.1kg) and total lean body mass (LBM) increased (0.5±2.0kg) overall, but there was variability among individual participants. There was an increase in % total LBM (1.4±1.9%) and decrease in % total body fat mass (-1.5±2.0%) after ET. Interestingly, each standard deviation (SD) increase in baseline FG (mean=135.5mg/dl; SD=39.0mg/dl) was related to a significant increase in % total LBM (0.54±0.26%, p=0.048) and decrease in % total body fat (-0.57±0.27%, p=0.04) after ET among individual participants. CONCLUSIONS: Our data demonstrate that muscle gains and fat loss after ET are positively related to baseline hyperglycemia. Further studies are needed to characterize differences in metabolic response following ET among persons with diabetes.
RCT Entities:
AIMS: Exercise training (ET) has been variably associated with body composition changes among persons with type 2 diabetes (T2DM). The degree to which these changes are related to hyperglycemia remains unclear. Our objective was to investigate the relationship of baseline fasting glucose (FG) to the magnitude of muscle gains and fat loss after ET in individuals with T2DM. METHODS:Participants were enrolled in the SHAPE-2 trial, a six month supervised aerobic and resistance training intervention (three days/week), at Johns Hopkins. This was a post hoc single arm intervention study of participants who completed the exercise intervention (n=50). Participants were aged 40-65years and had T2DM that was not treated with insulin. Body composition was assessed by DEXA. RESULTS: After 6months of ET, total fat mass decreased (-2.1±3.1kg) and total lean body mass (LBM) increased (0.5±2.0kg) overall, but there was variability among individual participants. There was an increase in % total LBM (1.4±1.9%) and decrease in % total body fat mass (-1.5±2.0%) after ET. Interestingly, each standard deviation (SD) increase in baseline FG (mean=135.5mg/dl; SD=39.0mg/dl) was related to a significant increase in % total LBM (0.54±0.26%, p=0.048) and decrease in % total body fat (-0.57±0.27%, p=0.04) after ET among individual participants. CONCLUSIONS: Our data demonstrate that muscle gains and fat loss after ET are positively related to baseline hyperglycemia. Further studies are needed to characterize differences in metabolic response following ET among persons with diabetes.
Authors: O G Geirsdottir; A Arnarson; K Briem; A Ramel; P V Jonsson; I Thorsdottir Journal: J Gerontol A Biol Sci Med Sci Date: 2012-04-10 Impact factor: 6.053
Authors: Ronald J Sigal; Glen P Kenny; Normand G Boulé; George A Wells; Denis Prud'homme; Michelle Fortier; Robert D Reid; Heather Tulloch; Douglas Coyle; Penny Phillips; Alison Jennings; James Jaffey Journal: Ann Intern Med Date: 2007-09-18 Impact factor: 25.391
Authors: Javier Ibáñez; Esteban M Gorostiaga; Alicia M Alonso; Luis Forga; Iñaki Argüelles; José L Larrión; Mikel Izquierdo Journal: J Diabetes Complications Date: 2008 Mar-Apr Impact factor: 2.852
Authors: Rita R Kalyani; Jing Tian; Qian-Li Xue; Jeremy Walston; Anne R Cappola; Linda P Fried; Frederick L Brancati; Caroline S Blaum Journal: J Am Geriatr Soc Date: 2012-08-10 Impact factor: 5.562
Authors: S F E Praet; R A M Jonkers; G Schep; C D A Stehouwer; H Kuipers; H A Keizer; L J van Loon Journal: Eur J Endocrinol Date: 2008-02 Impact factor: 6.664
Authors: Henry J Pownall; George A Bray; Lynne E Wagenknecht; Michael P Walkup; Stanley Heshka; Van S Hubbard; James Hill; Steven E Kahn; David M Nathan; Anne V Schwartz; Karen C Johnson Journal: Obesity (Silver Spring) Date: 2015-03 Impact factor: 5.002
Authors: Mary O Whipple; Erica N Schorr; Kristine M C Talley; Ruth Lindquist; Ulf G Bronas; Diane Treat-Jacobson Journal: J Aging Phys Act Date: 2018-06-20 Impact factor: 1.961
Authors: Simona S Ghanem; Harrison T Muturi; Anthony M DeAngelis; Jiang Hu; Rohit N Kulkarni; Garrett Heinrich; Sonia M Najjar Journal: Diabetologia Date: 2017-05-31 Impact factor: 10.122
Authors: Camilla Rodrigues de Souza Silva; André Dos Santos Costa; Taciano Rocha; Diogo Arruda Martins de Lima; Tamires do Nascimento; Sílvia Regina Arruda de Moraes Journal: PLoS One Date: 2018-10-18 Impact factor: 3.240